GlassScriptPhysician profile
Roderick Jay Baltzer
NPI 1760564041
$5,670.95
in general payments reported to CMS, 2019-2025
34 companies · $1,283 in 2025
The $1,283 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,448 · 2020: $321 · 2021: $279 · 2022: $452 · 2023: $604 · 2024: $1,283 · 2025: $1,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,137 · Education: $32.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,137.48 |
| Education | $32.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,388.85 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $753.84 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $316.86 | 2019-2025 | Jardiance, Tradjenta |
| Abbvie INC. | $314.88 | 2022-2025 | Qulipta, Ubrelvy |
| Pfizer INC. | $277.61 | 2019-2025 | |
| Amgen INC. | $233.88 | 2019-2025 | Evenity, Prolia, Otezla |
| Novartis Pharmaceuticals Corporation | $184.13 | 2019 | |
| Exact Sciences Corporation | $144.76 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $142.82 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Merck Sharp & Dohme LLC | $127.75 | 2019-2025 | Keytruda, Vaxneuvance, Gardasil 9 |
| Astellas Pharma US INC | $107.12 | 2019-2025 | Veozah, Xospata |
| Sunovion Pharmaceuticals INC. | $84.74 | 2019 | |
| Sanofi-Aventis U.S. LLC | $69.48 | 2019 | |
| Glaxosmithkline, LLC. | $55.00 | 2019-2024 | Trelegy Ellipta |
| Daiichi Sankyo INC. | $39.98 | 2025 | Injectafer |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $36.99 | 2024 | Zoladex |
| Janssen Biotech, INC. | $34.95 | 2024-2025 | Tecvayli, Darzalex, Talvey |
| Aveo Pharmaceuticals, INC. | $32.63 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $27.62 | 2019 | |
| Geron Corporation | $26.08 | 2025 | Rytelo |
| Eisai INC. | $25.13 | 2025 | |
| Bioventus LLC | $25.02 | 2025 | Durolane |
| Janssen Pharmaceuticals, INC | $24.27 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $23.71 | 2025 | Onivyde |
| Corcept Therapeutics | $21.12 | 2025 | Korlym |
| Emd Serono, INC. | $20.82 | 2025 | |
| Xeris Pharmaceuticals, INC. | $20.57 | 2025 | Gvoke Hypopen |
| Jazz Pharmaceuticals INC. | $19.91 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $19.48 | 2025 | Opdivo |
| Abiomed | $17.92 | 2025 | |
| Sobi, INC | $14.34 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.76 | 2024 | Eohilia |
| Avanir Pharmaceuticals, INC. | $12.78 | 2019 | |
| Allergan, INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roderick Baltzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.